logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Opioid Agonist class drugs

    FiltersReset Filters
    18 results

    • conzip

      (tramadol hydrochloride)
      Vertical Pharmaceuticals, LLC
      Usage: CONZIP is indicated for managing severe, persistent pain requiring long-term opioid treatment when other options are insufficient. It should be reserved for patients intolerant of or unresponsive to non-opioid or immediate-release opioids due to risks of addiction, abuse, and overdose from long-acting opioids. It is not for as-needed use.

    • demerol

      (MEPERIDINE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: DEMEROL Injection is indicated for preoperative medication, anesthesia support, obstetrical analgesia, and managing severe pain when alternative treatments are inadequate. It is reserved for patients who cannot tolerate other options and should not be used long-term due to risks of addiction and toxicity.

    • dsuvia

      (Sufentanil)
      AcelRx Pharmaceuticals, Inc.
      Usage: DSUVIA is indicated for adults in certified healthcare settings for managing acute pain severe enough to require an opioid analgesic when alternative treatments are inadequate. It is not for home use, children, or longer than 72 hours, and must be administered by a healthcare provider.

    • fentanyl citrate

      (FENTANYL CITRATE)
      Hospira, Inc.
      Usage: Fentanyl Citrate Injection is indicated for short-duration analgesia during anesthesia, premedication, induction and maintenance of general or regional anesthesia, and postoperative recovery. It can also be used as an adjunct with neuroleptics in high-risk surgical patients.

    • fentanyl transdermal

      (fentanyl transdermal)
      SpecGx LLC
      Usage: Fentanyl transdermal system is indicated for managing severe, persistent pain in opioid-tolerant patients requiring long-term opioid therapy when other treatments are inadequate. It is not meant for as-needed use and carries risks of addiction and misuse.

    • hydrocodone bitartrate and acetaminophen

      (Hydrocodone Bitartrate and Acetaminophen)
      SpecGx LLC
      Usage: Hydrocodone bitartrate and acetaminophen tablets are indicated for managing severe pain requiring opioid analgesics when alternative treatments are insufficient. Due to risks of addiction and misuse, they should be reserved for patients who cannot tolerate or have not responded adequately to other pain relief options.

    • hydrocodone bitartrate and acetaminophen

      (HYDROCODONE BITARTRATE AND ACETAMINOPHEN)
      SpecGx LLC
      Usage: Hydrocodone bitartrate and acetaminophen tablets are indicated for managing severe pain requiring an opioid analgesic when alternative treatments are inadequate. Due to risks of addiction and misuse, they should be reserved for patients intolerant to or not adequately relieved by non-opioid analgesics. Avoid prolonged use unless necessary.

    • hydromorphone hydrochloride

      (HYDROMORPHONE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: Hydromorphone Hydrochloride Injection is indicated for severe pain management requiring an opioid analgesic when alternative treatments are inadequate. It is recommended for patients who cannot tolerate or achieve adequate relief from non-opioid analgesics or combination products, with caution due to risks of addiction and misuse.

    • hydromorphone hydrochloride

      (HYDROMORPHONE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: Hydromorphone Hydrochloride Injection is indicated for managing severe pain requiring opioid analgesics when alternative treatments are insufficient. It is reserved for patients intolerant to or not adequately managed by non-opioid analgesics or combination products, due to risks of addiction, abuse, and misuse.

    • hydromorphone hydrochloride

      (Hydromorphone Hydrochloride)
      Trigen Laboratories, LLC
      Usage: Hydromorphone hydrochloride extended-release tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. They are not intended for as-needed use and should be reserved for patients who are opioid-tolerant due to associated risks of addiction and overdose.